SPL RF Jan 2021
EN_01459393_0246
![SPL RF Jan 2021](img/medium/arch35/dvd0424/66/EN_01459393_0246.jpg)
SPECIAL RATES FOR EDITORIAL AND BOOKS
RF RATES FOR OTHER USE - INTERNET +100%
Internet +100%
Illustration of a person being vaccinated against Covid-19. An injection has stimulated the production of different antibodies against proteins (blue) on the SARS-CoV-2 virus that causes Covid-19. The presence of the antibodies mean that the body is primed to attack the virus when it is next encountered, preventing disease. The first vaccine, developed by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.
2021-01-02
DESIGN CELLS/Science Photo Library RF/East News
Science Photo Library RF
DESIGN CELLS
f0325817
5,89MB
61cm x 34cm by 300dpi
ANTIBODIES, ANTIBODY, ARTWORK, BACKGROUND, BIOLOGICAL, BIOLOGY, BODY, CELLS, CONCEPTS, CONCEPTUAL, CONDITION, CORONAVIRUS, COVID-19, DESIGN, DISEASE, DISORDER, EPIDEMIC, GREY, HCOV, HUMAN, ILLUSTRATION, IMMUNE, IMMUNISATION, IMMUNISING, IMMUNITY, IMMUNIZING, IMMUNOGLOBULIN, IMMUNOLOGICAL, IMMUNOLOGY, INJECTING, INJECTION, NO-ONE, NOBODY, PANDEMIC, RESPONSE, SARS-COV, SARS-COV-2, SYSTEM, VACCINATING, VACCINATION, VACCINE, VIRAL, VIRUS,